Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany
 
 
 
 

Biosimilars

As part of our ambition to offer high-value solutions, we have set up a dedicated Biosimilars business to provide access to high-quality biologics to more patient all over the world. The business is developing a biosimilar portfolio focused on oncology and inflammatory disorders.

More in M – The Explorer Magazine:

DISCLAIMER

Publication of Merck KGaA, Darmstadt, Germany.
There are two different, unaffiliated companies that use the name MERCK. Merck KGaA, Darmstadt, Germany, which operates this website, uses the firm name “Merck KGaA, Darmstadt, Germany,” in the United States and Canada, and also uses “EMD Serono” in biopharma, “MilliporeSigma” in life science and “EMD Performance Materials” in materials business. The other company, Merck & Co., Inc. holds the rights in the trademark MERCK in the United States and Canada. Merck & Co. is not affiliated with or related to Merck KGaA, Darmstadt, Germany, which owns the MERCK trademark in all other countries of the world.   To reflect such fact and to avoid any confusion, certain logos, terms and business descriptions of the publications on this website have been substituted or modified, such as by referring to “Merck KGaA, Darmstadt, Germany” instead of “Merck” standing alone.  Publications on this webpage, therefore, slightly deviate from the otherwise identical versions accessible outside the United States and Canada.
 

CONTACT INFORMATION



Z.I. de l'Ouriettaz
Aubonne  CH-1170
Switzerland